Tarsus Pharmaceuticals is a biopharmaceutical company dedicated to creating new categories in eye care and beyond, focusing on diseases with high unmet needs
Tarsus Pharmaceuticals is a biopharmaceutical company dedicated to creating new categories in eye care and beyond, focusing on diseases with high unmet needs. They have developed the first FDA-approved treatment for Demodex blepharitis and are advancing a robust pipeline to address other significant conditions.